{
    "Overall_score": {
        "Correlation": 7,
        "Sentiment": 6,
        "Importance": 5,
        "Impact": 6,
        "Duration": 4,
        "Virality": 3,
        "Source_Score": 8,
        "Specificity": 6,
        "Sector_Spread": 7,
        "Tech_Mentions": 2
    },
    "Each_item": [
        {
            "News_content": "RT @theflynews: $GILD $ESRX $MRK $ABBV $BMY $ABT Gilead defended by analysts after recent pullback",
            "Correlation": 9,
            "Sentiment": 7,
            "Importance": 6,
            "Impact": 7,
            "Duration": 3,
            "Virality": 4,
            "Source_Score": 8,
            "Specificity": 8,
            "Sector_Spread": 6,
            "Tech_Mentions": 1
        },
        {
            "News_content": "GS hepC survey data: expect to use this regimen in 30% of their patients if priced on par to GILDâ€™s regimen, 2x higher than consensus $ABBV",
            "Correlation": 8,
            "Sentiment": 6,
            "Importance": 7,
            "Impact": 7,
            "Duration": 5,
            "Virality": 3,
            "Source_Score": 9,
            "Specificity": 9,
            "Sector_Spread": 4,
            "Tech_Mentions": 2
        },
        {
            "News_content": "Would you like great research on stocks $FE $FITB $ABBV $AAPL Must have",
            "Correlation": 5,
            "Sentiment": 5,
            "Importance": 4,
            "Impact": 4,
            "Duration": 2,
            "Virality": 2,
            "Source_Score": 6,
            "Specificity": 5,
            "Sector_Spread": 8,
            "Tech_Mentions": 1
        }
    ]
}